Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0268596 (
EMA
)
2,520
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ecological momentary assessment (
EMA
; Stone & Shiffman, 1994) was utilized to examine affective instability (AI) in the daily lives of outpatients with borderline personality disorder (BPD;
n
=78) with and without posttraumatic stress disorder (PTSD). A psychiatric control group (
n
=50) composed of outpatients with major depressive disorder/dysthymia (
MDD
/DYS) was employed to compare across subgroups: BPD-only, BPD+PTSD,
MDD
/DYS-only, and
MDD
/DYS+PTSD. Compared to the BPD-only group, the BPD+PTSD group had significantly greater instability of fear and sadness, but did not significantly differ in instability of hostility or aggregate negative affect. This pattern of elevated instability of fear and sadness was not present-and, in fact, was reversed-in the
MDD
/DYS group. Results emphasize the importance of examining AI within the context of specific comorbidities and affect types. Treatment and research addressing AI in the context of BPD-PTSD comorbidity may benefit from a focus on fear and sadness as separate from hostility or general negative affect.
...
PMID:Negative Affect Instability among Individuals with Comorbid Borderline Personality Disorder and Posttraumatic Stress Disorder. 2690 88
Omega-3 long-chain polyunsaturated fatty acid (
n
-3 FA) status may be associated with mood disorders. Here, we evaluated the potential association between antenatal depression/anxiety and
n
-3/
n
-6 FA in (a) maternal erythrocytes and (b) human milk. In addition, we explored associations between
n
-3/
n
-6 FA in erythrocytes and in human milk and postpartum depression, while controlling for antenatal depression. Twenty-seven pregnant women diagnosed with a current major depressive disorder (
MDD
;
n
= 9), anxiety disorder (AD;
n
= 10) or a mixed anxiety-depression disorder (
MADD
;
n
= 8), and 40 healthy controls were included.
n
-3/
n
-6 FA were determined in maternal erythrocytes in gestational week 32 and in human milk in postpartum week 1. In the first week postpartum, the
Edinburgh
-
Postnatal
-
Depression
-
Questionnaire
was used to assess postpartum depression. Results show that women with M(A)DD had significantly lower erythrocyte levels of total
n
-3 FA, EPA, DHA and DGLA, and significantly higher
n
-6 DPA, and
n
-6:
n
-3, AA:EPA and
n
-6 DPA:DHA ratios compared to healthy controls. No significant associations between antenatal depression or anxiety and
n
-3/
n
-6 FA in human milk were found. After controlling for antenatal mental health,
n
-3/
n
-6 FA in maternal erythrocytes or in human milk were not significantly associated with postpartum depression. In conclusion, antenatal depression, alone or with an anxiety disorder, was associated with lower
n
-3 FA levels and higher
n
-6:
n
-3 FA ratios in maternal erythrocytes during gestation. This study provides some insights into the associations between
n
-3/
n
-6 FA levels during pregnancy and lactation and perinatal mental health.
...
PMID:Levels of
n
-3 and
n
-6 Fatty Acids in Maternal Erythrocytes during Pregnancy and in Human Milk and Its Association with Perinatal Mental Health. 3293 15